Evidence map›Paper›PMID 27334608›Full record

ArticleCritical care (London, England)2016

The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients.

F Garzotto, M Ostermann, D Martín-Langerwerf, M Sánchez-Sánchez, J Teng, R Robert, A Marinho, M E Herrera-Gutierrez, H J Mao, D Benavente and 6 more

Abstract read
In one paragraph

Article in Critical care (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Ultrafiltration Tolerance and Improving Outcomes with Continuous Renal Replacement Therapies.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
  11. Review
  12. Continuous Kidney Replacement Therapy in Pediatric Intensive Care Unit: Little People, Big Gaps.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Article
  13. Review
  14. Review
  15. Article
  16. Observational
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

F GarzottoDepartment of Nephrology Dialysis and Transplantation, San Bortolo Hospital, 37 Via Rodolfi, 36100, Vicenza, Italy. f.garzotto@gmail.com.
M OstermannDepartment of Critical Care, King's College London, Guy's and St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK.
D Martín-LangerwerfServicio de Medicina Intensiva, Hospital Universitario del Vinalopo, Calle Tonico Sansano Mora, 14, 03283, Elche, Spain.
M Sánchez-SánchezIntensive Care, Hospital Universitario La Paz/Carlos III. IdiPAZ, Paseo Castellana 261, 28046, Madrid, Spain.
J TengDepartment of Nephrology, Shanghai Institute of Kidney and Dialysis, Shanghai Key Laboratory of Kidney and Blood Purification, Zhongshan Hospital, Fudan University, 180 Fenglin Road, 200032, Shanghai, China.
R RobertMedical Intensive Care, University of Poitiers; CHU Poitiers, 2, rue de la Milétrie, Poitiers, 86021, France.
A MarinhoIntensive Care Service, St Antonio Hospital - Porto, Largo Prof. Abel Salazar, 4099-001, Porto, Portugal.
M E Herrera-GutierrezIntensive Care Unit, General University Hospital, Avd Carlos Haya s/n, Malaga, 29010, Spain.
H J MaoDepartment of Nephrology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, 210029, Nanjing, Jiangsu, China.
D BenaventeDepartment of Nephrology, Clinica Las Condes, Estoril 450, Las Condes, 7591283, Santiago, Chile.
E KipnisDepartment of Anesthesiology and Critical Care, University Hospital, EA 7366, Lille, 59000, France.
A LorenzinInternational Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, 37 Via Rodolfi, 36100, Vicenza, Italy.
D MarcelliFresenius Medical Care, Else-Kröner-Straße 1, 61352 Bad, Homburg, Germany.
C TettaFresenius Medical Care, Else-Kröner-Straße 1, 61352 Bad, Homburg, Germany.
C RoncoDepartment of Nephrology Dialysis and Transplantation, San Bortolo Hospital, 37 Via Rodolfi, 36100, Vicenza, Italy.
DoReMIFA study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe previously published "Dose Response Multicentre International Collaborative Initiative (DoReMi)" study concluded that the high mortality of critically ill patients with acute kidney injury (AKI) was unlikely to be related to an inadequate dose of renal replacement therapy (RRT) and other factors were contributing. This follow-up study aimed to investigate the impact of daily fluid balance and fluid accumulation on mortality of critically ill patients without AKI (N-AKI), with AKI (AKI) and with AKI on RRT (AKI-RRT) receiving an adequate dose of RRT.

methodsWe prospectively enrolled all consecutive patients admitted to 21 intensive care units (ICUs) from nine countries and collected baseline characteristics, comorbidities, severity of illness, presence of sepsis, daily physiologic parameters and fluid intake-output, AKI stage, need for RRT and survival status. Daily fluid balance was computed and fluid overload (FO) was defined as percentage of admission body weight (BW). Maximum fluid overload (MFO) was the peak value of FO.

resultsWe analysed 1734 patients. A total of 991 (57 %) had N-AKI, 560 (32 %) had AKI but did not have RRT and 183 (11 %) had AKI-RRT. ICU mortality was 22.3 % in AKI patients and 5.6 % in those without AKI (p < 0.0001). Progressive fluid accumulation was seen in all three groups. Maximum fluid accumulation occurred on day 2 in N-AKI patients (2.8 % of BW), on day 3 in AKI patients not receiving RRT (4.3 % of BW) and on day 5 in AKI-RRT patients (7.9 % of BW). The main findings were: (1) the odds ratio (OR) for hospital mortality increased by 1.075 (95 % confidence interval 1.055-1.095) with every 1 % increase of MFO. When adjusting for severity of illness and AKI status, the OR changed to 1.044. This phenomenon was a continuum and independent of thresholds as previously reported. (2) Multivariate analysis confirmed that the speed of fluid accumulation was independently associated with ICU mortality. (3) Fluid accumulation increased significantly in the 3-day period prior to the diagnosis of AKI and peaked 3 days later.

conclusionsIn critically ill patients, the severity and speed of fluid accumulation are independent risk factors for ICU mortality. Fluid balance abnormality precedes and follows the diagnosis of AKI.

Indexed as

Dose-Response Relationship, DrugAcute Kidney InjuryAdultAgedCritical IllnessFemaleFollow-Up StudiesHumansIntensive Care UnitsMaleMiddle AgedProspective StudiesRenal Replacement TherapyRisk FactorsWater-Electrolyte ImbalanceAKICritical illnessFluid overloadICURRT

Identifiers

PMID27334608
PMCPMC4918119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.